Arthur Taveras

Insider Reports History

Entity
Individual
Location
C/O X4 Pharmaceuticals, Inc., 61 North Beacon Street, 4 Th Floor, Boston, MA
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur Taveras:

Stock Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Scientific Officer Common Stock 388K $218K $0.56 Oct 7, 2024 Direct
X4 Pharmaceuticals, Inc Chief Scientific Officer Stock Appreciation Right 428K Feb 13, 2024 Direct

Insider Reports Filed by Arthur Taveras

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XFOR X4 Pharmaceuticals, Inc Oct 4, 2024 2 -$43.3K 4 Oct 8, 2024 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Mar 11, 2024 1 -$12.6K 4 Mar 11, 2024 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Feb 13, 2024 1 $0 4 Feb 16, 2024 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Feb 12, 2024 1 -$793 4 Feb 12, 2024 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Nov 1, 2023 1 -$49.4K 4 Nov 3, 2023 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Oct 31, 2023 1 $0 4 Nov 2, 2023 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Mar 10, 2023 1 -$14.1K 4 Mar 13, 2023 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Feb 13, 2023 1 -$863 4 Feb 15, 2023 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Nov 7, 2022 1 $0 4 Nov 9, 2022 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Mar 1, 2022 1 $0 4 Mar 1, 2022 Chief Scientific Officer
XFOR X4 Pharmaceuticals, Inc Feb 11, 2022 1 $0 4 Feb 14, 2022 Chief Scientific Officer